Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,066,066
-$81,968,300 QoQ
Shares Held
3,390
-96.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,872
of 4,605 holders
Holding Since
Jun 2020
19 quarters on record
Voting authority
Sole 41%
Shared 59%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$9,715,383
PutShares
8,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LMR Partners LLP holds $144,798,606 across 13 Drug Manufacturers - General names. LLY ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GSK |
GSK plc
|
980,479 | $51,396,709 | |
| 2 | NVS |
Novartis AG
|
153,726 | $24,091,938 | |
| 3 | ABBV |
AbbVie Inc.
|
79,736 | $20,064,766 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
330,151 | $19,023,300 | |
| 5 | PFE |
Pfizer Inc
|
260,990 | $6,284,639 | |
| 6 | MRK |
Merck & Co., Inc.
|
44,030 | $5,657,855 | |
| 7 | OGN |
Organon & Co.
|
396,842 | $5,373,240 | |
| 8 | LLY |
ELI LILLY & Co
This page
|
3,390 | $4,066,066 |
All Filings in LLY
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,066,066 | 3,390 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $9,715,383 | 8,100 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $52,702,821 | 57,300 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $86,034,366 | 93,539 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $165,834,531 | 180,300 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $19,129,305 | 17,800 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $11,855,870 | 11,032 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $2,289,000 | 3,000 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $980,455 | 1,285 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $75,380,551 | 96,700 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $113,343,662 | 145,400 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $5,318,733 | 6,823 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $49,224,236 | 59,600 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $5,371,718 | 6,504 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $79,865,497 | 96,700 | Put | Sole | 2025-05-15 | |
| 2024-12-31 | $42,846,000 | 55,500 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $2,495,876 | 3,233 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,781,191 | 4,268 | Shares | Sole | 2024-11-07 | |
| 2024-09-30 | $39,867,300 | 45,000 | Call | Sole | 2024-11-07 | |
| 2024-06-30 | $451,784 | 499 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $4,225,100 | 5,431 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $27,397,240 | 47,000 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $6,820,164 | 11,700 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $13,374,537 | 24,900 | Put | Sole | 2023-11-14 | |
| 2023-09-30 | $21,431,487 | 39,900 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $84,791,584 | 180,800 | Put | Sole | 2023-08-14 | |
| 2023-06-30 | $18,712,302 | 39,900 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $10,048,812 | 29,261 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $17,942,256 | 49,044 | Shares | Sole | 2023-02-14 | |
| 2021-09-30 | $5,496,448 | 23,789 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $309,163 | 1,347 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $309,934 | 1,659 | Shares | Sole | 2021-05-17 | |
| 2020-06-30 | $5,067,744 | 30,867 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||